DDN October 2017 DDN_DIR_October2017 | Page 9

comment More help and resources at www.drinkanddrugsnews.com Within our grasp ResouRces coRneR W George Allan finds FEAD to be a website worth saving We can win the war against hepatitis C but we need to seize the opportunity, says Dee Cunniffe e have seen great strides in the development of treatment for hepatitis C in recent years. Revolutionary new drugs for this life- threatening disease, which can result in cirrhosis, liver failure or liver cancer, can save people’s lives and make a real difference. But the battle has not yet been won. Despite the introduction in 2014 of new direct-acting antiviral drugs, which can cure hepatitis C in more than nine out of ten cases, there remain huge barriers to those attempting to access treatment. Through our new report, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) reveals that increasing the number of people treated with these medicines offers the potential to halve disease burden in ten to 20 years. This is an exciting and important opportunity in our efforts to reduce the number of people dying from the disease by 65 per cent before 2030. However, significant action and progress is needed to enable access to these life-saving drugs – especially for the vulnerable, socially excluded sections of the population who inject drugs. Furthermore, this isn’t just about increasing access to the treatments themselves. With 40 per cent of people living with hepatitis C in London estimated to be undiagnosed, access is only half the battle. To successfully eliminate the disease, we need to ensure this ‘silent killer’, which often remains undetected for many years without symptoms, is diagnosed effectively. This will require services to shift their approach across the patient pathway, from improving testing regimes to enabling better access to drugs. Current service provision across the country, and particularly in London, is often patchy, disjointed and unable to support the needs of vulnerable, socially excluded populations such as people who inject drugs. SO, WHAT CAN WE DO TO IMPROVE SERVICES? Firstly, we need to ensure there is more ‘joined-up’ thinking across services in all London boroughs. Improved coordination will enable patients to receive the testing and treatment they need, where and when they access it. Joint commissioning arrangements should also be developed between clinical commissioning groups (CCGs) and public health to ensure robust and deliverable pathways are established. Secondly, all boroughs should create and implement a strategy specifically targeted at addressing liver disease and hepatitis C. An important area to be tackled here is reaching people who inject drugs. This remains the major risk factor for becoming infected. Our third key call is for hepatitis C antibody testing to be offered in more places across the capital. Testing sho uld be accessible at all drug treatment services and other venues, such as needle and syringe exchange programmes, as well as in pharmacies. While significant challenges remain to successfully eliminating hepatitis C, our findings offer hope that we can significantly reduce the number of lives lost to the virus. Joining up services and improving access to these revolutionary life-saving drugs can enable us to halve the disease burden in ten to 20 years, helping us on our way to achieving our targets. This might seem ambitious, but with the right structural changes, it’s firmly within our reach. Dee Cunniffe is a policy lead on the London Joint Working Group on Substance Use and Hepatitis C (LJWG) www.drinkanddrugsnews.com Valuable viewing The recent demise of Lifeline calls into question the continued existence of the Film Exchange on Alcohol and Drugs (FEAD). This website (www.fead.org.uk) was set up in 2008 by Lifeline as a platform for sharing the experience and knowledge of central figures in the field. The site has never received significant publicity, which is a shame as it contains a wealth of material which can both educate and challenge. The site contains two types of video. Firstly, there are clips of individual ‘talking heads’ presenting their views on aspects of theory, policy or service provision. These usually last less than five minutes, ensuring that presenters concentrate on the core of their arguments. Secondly, the site includes full presentations from conferences run by organisations such as UK SMART Recovery, the New Directions in the Study of Alcohol Group and Scotland’s Futures Forum. The richness, depth and variety of the ground covered is impressive. Here you will find such diverse inputs as Nick Heather on the confusion between moderating alcohol consumption and controlled drinking, Joy Barlow on early work with drug-using mothers and John Davies on how ‘addiction’ is socially constructed and the implications of this for treatment and policy. The opinions expressed cannot fail to enlighten, inspire or provoke. The viewer may be surprised. If you think you can guess what Neil McKeganey’s attitudes towards supervised injecting facilities might be, or David Best’s views of risk reduction approaches, then you may have to reconsider. The site was established around the time when ‘recovery’ was emerging as a contentious issue and this has ensured that the topic is given a good airing. While a neat definition continues to elude us, the views of such luminaries as William White, Griffith Edwards and Annette Dale-Perera help to shed light on a slippery concept. Fifteen minutes on the site is guaranteed to encourage viewers to step back from immediate pressures and immerse themselves in aspects of the bigger picture. As teaching aids the short videos are invaluable. The material is also an important historical record: for this reason alone, it is essential that the site continues and it is hoped that another organisation will take it over and maintain and develop it. ‘Fifteen minutes on the site is guaranteed to encourage viewers to step back from immediate pressures and immerse themselves in aspects of the bigger picture. As teaching aids the short videos are invaluable.’ George Allan is chair of Scottish Drugs Forum. He is the author of Working with Substance Users: A Guide to Effective Interventions (2014; Palgrave). October 2017 | drinkanddrugsnews | 9